Yanqi Xie
-
- Nanoparticle-Based Drug Delivery 5
- Pharmaceutical Science top 10%
-
- Cancer Genomics and Diagnostics 2
-
- Berberine and alkaloids research 2
-
- Epigenetics and DNA Methylation 2
- RNA Interference and Gene Delivery 2
- Wnt/β-catenin signaling in development and cancer 2
-
- Cancer-related Molecular Pathways 3
-
- Vitamin C and Antioxidants Research 2
- Journals
- Bioinformatics (1 paper)Scientific Reports (1 paper)Journal of Controlled Release (1 paper)
- Partner nations
- ChinaUnited StatesUkraine
In The Last Decade
Yanqi Xie
20 papers receiving 395 citations
Peers
Comparison fields: 5 of 68
- Biomaterials 75
- Pharmaceutical Science 29
- Cancer Research 63
- Pharmacology 69
- Molecular Biology 225
Countries citing papers authored by Yanqi Xie
This map shows the geographic impact of Yanqi Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanqi Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanqi Xie more than expected).
Fields of papers citing papers by Yanqi Xie
This network shows the impact of papers produced by Yanqi Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanqi Xie. The network helps show where Yanqi Xie may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yanqi Xie, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2024 | 7 | |
| 3 | 2021 | 6 | |
| 4 | 2020 | 17 | |
| 5 | 2020 | 6 | |
| 6 | 2019 | 18 | |
| 7 | 2019 | 19 | |
| 8 | 2019 | 1 | |
| 9 | 2018 | 80 | |
| 10 | 2018 | 12 | |
| 11 | 2017 | 3 | |
| 12 | 2017 | 25 | |
| 13 | 2016 | 2 | |
| 14 | 2016 | 39 | |
| 15 | 2015 | 17 | |
| 16 | 2014 | 7 | |
| 17 | 2014 | 31 | |
| 18 | 2013 | 57 | |
| 19 | 2013 | 28 | |
| 20 | 2013 | 25 |
About Yanqi Xie
Yanqi Xie is a scholar working on Biomaterials, Cancer Research and Pharmaceutical Science, having authored 20 papers that have together received 402 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (5 papers), Cancer-related Molecular Pathways (3 papers), Berberine and alkaloids research (2 papers), Epigenetics and DNA Methylation (2 papers), RNA Interference and Gene Delivery (2 papers), Vitamin C and Antioxidants Research (2 papers), Cancer Genomics and Diagnostics (2 papers) and Wnt/β-catenin signaling in development and cancer (2 papers). The work is most often cited by research in Biomaterials (75 citations), Pharmaceutical Science (29 citations) and Cancer Research (63 citations). Yanqi Xie has collaborated with scholars based in China, United States and Ukraine. Frequent co-authors include Haiyan Hu, Wenbo Zhu, Yiwei Lin, Qiqi Mao, Liping Xie, Jia Song, Chuchu Lin, Kai Yang, Haibin Zhu and Xuan Yang. Their work appears in journals such as Bioinformatics, Scientific Reports and Journal of Controlled Release.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.